Information Library
Results for: Clinical Services - Phase II/III - Asia - Israel
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Energizing Enrollment
Case Study — October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
Partnering is Key to Maximizing Rewards in Emerging Markets
Press Release — September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.
-
Constant Vigilance
Case Study — March 16, 2011
Centralized planning played a key role in improving productivity during site visits and close monitoring ensured the high standards Quintiles put in place were met. -
Acute Coronary Syndrome - Tailored Solutions
Case Study — February 1, 2011
Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO. -
Managing Trauma
Case Study — September 14, 2010
Quintiles overcame the unpredictability of patient recruitment due to the emergency setup and the client was able to file for approval based on phase II data only. -
New FDA Guidance on Antidiabetic Therapies
White Paper — December 11, 2009
Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.
Page 1 of 1 (6 results)
